Join us for this Thought Leaders episode as Andy Beck, Co-Founder and CEO of PathAI, shares his vision for how artificial intelligence is shaping the future of pathology — from digital diagnostics to accelerating drug development.

Presenters

Hosted by Jonathan Tunstall, CEO and Founder of Pathology News, this Thought Leaders episode features an exclusive interview with:

Andy Beck, Co-Founder and CEO of PathAI

In this Thought Leaders conversation, we explore how PathAI is driving adoption of digital pathology and AI across both pharma and clinical settings. Andy reflects on his journey from academia to building one of the most influential companies in the field, the importance of trusted partnerships, and why digitisation is inevitable for the modern pathology lab.

We discuss PathAI’s approach to building integrated solutions that combine algorithms, workflows and diagnostic platforms, as well as their collaborations with Roche, Moffitt Cancer Center and Northwestern Medicine. Andy also shares his perspective on the balance between innovation and regulation, the rise of digital biomarkers, and how AI will increasingly support pathologists in delivering accurate, efficient and scalable diagnoses.

With insights from one of the industry’s leading voices, this episode offers a deep look into the next decade of pathology, and why AI will be at the heart of it.